William H. Herman

William H. Herman is a Professor of Epidemiology at the University of Michigan School of Public Health and Professor of Internal Medicine at the Medical School, holding the Stefan S. Fajans/GlaxoSmithKline Professorship of Diabetes while serving as Associate Medical Director at Blue Care Network. His career bridges clinical diabetes care, population health research, and health policy development.

His educational foundation includes:

• MD from Boston University School of Medicine (1979)
• MPH in Epidemiology from University of Michigan School of Public Health (1993)
• BS in Chemistry from Yale University (1975)

Dr. Herman's research program integrates diabetes epidemiology, health economics, and health services research to address critical gaps in diabetes prevention and management. His work emphasizes real-world effectiveness of interventions, cost-benefit analyses of emerging technologies, and policy implications for population health improvement, with particular focus on translating clinical trial findings into practical healthcare solutions.

Recent publications demonstrate consistent leadership in evaluating employer-sponsored prevention programs, real-world implementation of diabetes prevention protocols, and economic modeling of novel treatments like automated insulin delivery systems. These works collectively advance understanding of how healthcare system structures, payment models, and policy frameworks impact diabetes outcomes at scale.

His scientific recognition includes:

• American Diabetes Association's Kelly West Award for epidemiology (2006)

As principal investigator for landmark studies including DCCT, DPP, and GRADE, Dr. Herman has secured major NIH funding while currently leading five active projects addressing employer-based policy changes, real-world DPP effectiveness, GRADE economic analysis, automated insulin delivery systems, and CKD surveillance integration. His leadership extends to chairing the National Clinical Care Commission (2018-2021) whose congressional recommendations shaped federal diabetes policy, and directing key committees for NCQA and the American Diabetes Association.